Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Net Change in Cash : ¥11.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Wecome Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Zhejiang Wecome Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥-104.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥11.0 Mil.

Zhejiang Wecome Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Zhejiang Wecome Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Wecome Pharmaceutical Co Net Change in Cash Chart

Zhejiang Wecome Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

79.01

439.43

-314.06

-118.51

165.17

Zhejiang Wecome Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															50.18	227.51	-244.34	131.83	-104.01

Zhejiang Wecome Pharmaceutical Co Net Change in Cash Calculation

Zhejiang Wecome Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	58.289	+	9.313	+	97.572	+	0
	=	165.2

Zhejiang Wecome Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -16.439 + 153.561 + -241.13 + 0

= -104.0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Wecome Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Zhejiang Wecome Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Wecome Pharmaceutical Co Ltd (SZSE:300878) » Definitions » Net Change in Cash

Comparable Companies

SZSE:300583 SZSE:300404 SHSE:603739 SZSE:000504 SZSE:300147 SZSE:301166 SHSE:605177 SHSE:688137 SZSE:000710 SZSE:300238 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

N/A

Address

No. 2, Suisong Road, Lishui Economic Development Zone, Zhejiang Province, Lishui, CHN, 323000

Website

http://www.zjwk.com

Zhejiang Wecome Pharmaceutical Co Ltd is engaged in production and sales of modern Chinese medicine and western medicine. The company produces hard capsules, tablets, granules, soft capsules, pills (dropping pills).

Executives

Dai De Xiong Executives

Liu Zhong Liang Director

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Headlines

No Headlines